Back
Grace Therapeutics Stock Price Chart

Built for Lazy Summer Markets
Get instant access today.
Sell
50
GRCE
Grace Therapeutics
Last Price:
$3.11
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7

Slow Market? Try This Instead
See how it works now.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Grace Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.98 | Buy |
20-day SMA: | 2.96 | Buy |
50-day SMA: | 2.84 | Buy |
200-day SMA: | 3.06 | Sell |
8-day EMA: | 2.98 | Buy |
20-day EMA: | 2.95 | Buy |
50-day EMA: | 2.85 | Buy |
200-day EMA: | 2.92 | Buy |
Grace Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 56.29 | Buy |
Chaikin Money Flow: | 30600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.85 - 3.03) | Buy |
Bollinger Bands (100): | (2.32 - 3.14) | Buy |
Grace Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.02 while GRCE 8-day simple moving average is 2.98, which is a Buy signal.
-
The stock price of GRCE is 3.02 while Grace Therapeutics 20-day SMA is 2.96, which makes it a Buy.
-
Grace Therapeutics 50-day simple moving average is 2.84 while GRCE share price is 3.02, making it a Buy technically.
-
GRCE stock price is 3.02 and Grace Therapeutics 200-day simple moving average is 3.06, creating a Sell signal.
GRCE Technical Analysis vs Fundamental Analysis
Sell
50
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a SellThe current Grace Therapeutics [GRCE] share price is $3.02. The Score for GRCE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Grace Therapeutics Stock Info
Market Cap:
41.8M
Price in USD:
3.02
Share Volume:
50.3K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Sell
50
Grace Therapeutics (GRCE)
is a Sell
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 3.02 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.02 while GRCE 8-day exponential moving average is 2.98, which is a Buy signal.
-
The stock price of GRCE is 3.02 while Grace Therapeutics 20-day EMA is 2.95, which makes it a Buy.
-
Grace Therapeutics 50-day exponential moving average is 2.85 while GRCE share price is 3.02, making it a Buy technically.
-
GRCE stock price is 3.02 and Grace Therapeutics 200-day simple moving average is 2.92, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.06 per share, an increase this year of $0.23 per share, and an increase next year of $0.66 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Grace Therapeutics is a Buy
-
Grace Therapeutics Relative Strength Index (RSI) is 56.29, which suggest Grace Therapeutics is overbought
-
The Bollinger Bands (25) for Grace Therapeutics is (2.85 - 3.03), which suggest Grace Therapeutics is a Buy
-
The Bollinger Bands (100) for Grace Therapeutics is (2.32 - 3.14), which suggest Grace Therapeutics is a Buy
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.